Resveratrol: French paradox revisited

被引:315
作者
Catalgol, Betul [1 ]
Batirel, Saime [1 ]
Taga, Yavuz [1 ]
Ozer, Nesrin Kartal [1 ]
机构
[1] Marmara Univ, Fac Med, Dept Biochem, Genet & Metab Dis Res Ctr, TR-34668 Istanbul, Turkey
来源
FRONTIERS IN PHARMACOLOGY | 2012年 / 3卷
关键词
cancer; cardiovascular diseases; resveratrol; signal transduction; EPIDERMAL-GROWTH-FACTOR; NATURAL POLYPHENOLIC COMPOUND; ENDOTHELIAL PROGENITOR CELLS; ACTIVATED PROTEIN-KINASES; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; TRANS-RESVERATROL; RED WINE; OXIDATIVE STRESS; INDUCED APOPTOSIS;
D O I
10.3389/fphar.2012.00141
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Resveratrol is a polyphenol that plays a potentially important role in many disorders and has been studied in different diseases. The research on this chemical started through the "French paradox," which describes improved cardiovascular outcomes despite a high-fat diet in French people. Since then, resveratrol has been broadly studied and shown to have antioxidant, anti-inflammatory, anti-proliferative, and anti-angiogenic effects, with those on oxidative stress possibly being most important and underlying some of the others, but many signaling pathways are among the molecular targets of resveratrol. In concert they may be beneficial in many disorders, particularly in diseases where oxidative stress plays an important role. The main focus of this review will be the pathways affected by resveratrol. Based on these mechanistic considerations, the involvement of resveratrol especially in cardiovascular diseases, cancer, neurodegenerative diseases, and possibly in longevity will be is addressed.
引用
收藏
页数:18
相关论文
共 223 条
  • [1] Does a glass of red wine improve endothelial function?
    Agewall, S
    Wright, S
    Doughty, RN
    Whalley, GA
    Duxbury, M
    Sharpe, N
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (01) : 74 - 78
  • [2] Aggarwal BB, 2004, ANTICANCER RES, V24, P2783
  • [3] The NADPH Oxidase Nox4 and Aging in the Heart
    Ago, Tetsuro
    Matsushima, Shouji
    Kuroda, Junya
    Zablocki, Daniela
    Kitazono, Takanari
    Sadoshima, Junichi
    [J]. AGING-US, 2010, 2 (12): : 1012 - 1016
  • [4] Prooxidant activity of resveratrol in the presence of copper ions: Mutagenicity in plasmid DNA
    Ahmad, A
    Syed, FA
    Singh, S
    Hadi, SM
    [J]. TOXICOLOGY LETTERS, 2005, 159 (01) : 1 - 12
  • [5] Pro-oxidant activity of low doses of resveratrol inhibits hydrogen peroxide-induced apoptosis
    Ahmad, KA
    Clement, MV
    Pervaiz, S
    [J]. APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS, 2003, 1010 : 365 - 373
  • [6] Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
    Almeida, Luis
    Vaz-da-Silva, Manuel
    Falcao, Amilcar
    Soares, Eva
    Costa, Raquel
    Loureiro, Ana I.
    Fernandes-Lopes, Carlos
    Rocha, Jose-Francisco
    Nunes, Teresa
    Wright, Lyndon
    Soares-da-Silva, Patricio
    [J]. MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 : S7 - S15
  • [7] Resveratrol protects primary rat hepatocytes against oxidative stress damage: Activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes
    Andres Rubiolo, Juan
    Mithieux, Gilles
    Victor Vega, Felix
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 591 (1-3) : 66 - 72
  • [8] Resveratrol - A boon for treating Alzheimer's disease?
    Anekonda, Thimmappa S.
    [J]. BRAIN RESEARCH REVIEWS, 2006, 52 (02) : 316 - 326
  • [9] [Anonymous], 2003, WORLD CANC REPORT
  • [10] Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorylation
    Ashikawa, K
    Majumdar, S
    Banerjee, S
    Bharti, AC
    Shishodia, S
    Aggarwal, BB
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (11) : 6490 - 6497